IFEX (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the IFEX drug offered from Baxter Healthcare Corporation. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: ifosfamide
SUBSTANCE NAME: IFOSFAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1988-12-30
END MARKETING DATE: 0000-00-00


IFEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIFEX from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/20mL)
START MARKETING DATE: 1988-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-3991_5ec97e1e-34bb-428b-b837-72dece080855
PRODUCT NDC: 0338-3991
APPLICATION NUMBER: NDA019763

Other IFOSFAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCIfosfamide
Baxter Healthcare CorporationIFEX
Fresenius Kabi USA, LLCIfosfamide
Mylan Institutional LLCIfosfamide
Pfizer Laboratories Div Pfizer Inc.Ifosfamide
Teva Parenteral Medicines, Inc.Ifosfamide
West-Ward Pharmaceuticals CorpIfosfamide